Digirad Co. (NASDAQ:DRAD) saw a large increase in short interest during the month of July. As of July 31st, there was short interest totalling 23,400 shares, an increase of 9.3% from the June 30th total of 21,400 shares. Currently, 0.1% of the company’s shares are short sold. Based on an average trading volume of 12,500 shares, the days-to-cover ratio is currently 1.9 days.
Separately, ValuEngine cut Digirad from a “buy” rating to a “hold” rating in a research note on Tuesday, July 2nd.
NASDAQ DRAD remained flat at $$4.46 during trading hours on Friday. The company had a trading volume of 3,012 shares, compared to its average volume of 6,371. The business’s 50 day moving average price is $5.61 and its 200-day moving average price is $2.66. Digirad has a twelve month low of $4.20 and a twelve month high of $19.00. The company has a debt-to-equity ratio of 0.62, a quick ratio of 1.18 and a current ratio of 1.59.
An institutional investor recently bought a new position in Digirad stock. Weber Alan W bought a new position in shares of Digirad Co. (NASDAQ:DRAD) in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 100,000 shares of the medical equipment provider’s stock, valued at approximately $91,000. Weber Alan W owned approximately 0.49% of Digirad as of its most recent filing with the Securities and Exchange Commission.
Digirad Company Profile
Digirad Corporation provides healthcare solutions in the United States and internationally. It operates through three segments: Diagnostic Services, Mobile Healthcare, and Diagnostic Imaging. The Diagnostic Services segment provides nuclear and ultrasound imaging services to physicians who perform nuclear imaging, echocardiography, vascular or general ultrasound tests, imaging systems, radiopharmaceuticals, and licensing services.
Read More: What is Cost of Goods Sold (COGS)?
Receive News & Ratings for Digirad Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Digirad and related companies with MarketBeat.com's FREE daily email newsletter.